Arthur D. Levinson

Arthur D. Levinson, born on March 31, 1950, is a prominent American molecular biologist and business leader, currently serving as the chairman of Apple Inc. since two thousand eleven. His extensive career in the biotechnology sector includes a significant tenure as the chief executive officer of Calico, a venture under Alphabet Inc., where he focuses on health and longevity.

Levinson's leadership at Genentech, where he was CEO from nineteen ninety-five to two thousand nine and chairman from nineteen ninety-nine to two thousand fourteen, solidified his reputation in the industry. His strategic vision and innovative approach have been instrumental in advancing biopharmaceuticals.

In addition to his roles at Apple and Calico, Levinson has been an influential figure on various boards, including the Broad Institute and previously at Hoffmann-La Roche, NGM Biopharmaceuticals, and Amyris Biotechnologies. His contributions extend to advisory positions at prestigious institutions such as the Memorial Sloan Kettering Cancer Center and the California Institute for Quantitative Biosciences.

Levinson's commitment to scientific advancement is further demonstrated through his involvement with the advisory councils of Princeton University's Department of Molecular Biology and the Lewis-Sigler Institute for Integrative Genomics, showcasing his dedication to fostering innovation in the life sciences.